These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 19491860
1. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Am J Gastroenterol; 2009 Jun; 104(6):1460-7. PubMed ID: 19491860 [Abstract] [Full Text] [Related]
3. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A. Perit Dial Int; 2002 Oct; 22(1):60-6. PubMed ID: 11929146 [Abstract] [Full Text] [Related]
4. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906 [Abstract] [Full Text] [Related]
5. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Valério de Azevedo S, Maltez C, Lopes AI. Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956 [Abstract] [Full Text] [Related]
6. Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease. Danko I, Weidkamp M. J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e107-e111. PubMed ID: 27540710 [Abstract] [Full Text] [Related]
7. IBD: Intravenous iron in IBD--what's the best preparation? Gomollón F, Gisbert JP. Nat Rev Gastroenterol Hepatol; 2011 Jul 26; 8(9):477-8. PubMed ID: 21788975 [No Abstract] [Full Text] [Related]
10. Do two intravenous iron sucrose preparations have the same efficacy? Rottembourg J, Kadri A, Leonard E, Dansaert A, Lafuma A. Nephrol Dial Transplant; 2011 Oct 26; 26(10):3262-7. PubMed ID: 21355067 [Abstract] [Full Text] [Related]
11. [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. Ogi M, Horiuchi T, Abe R, Wakabayashi M, Wakabayashi T. Nihon Jinzo Gakkai Shi; 2004 Oct 26; 46(8):804-9. PubMed ID: 15645737 [Abstract] [Full Text] [Related]
12. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD, FIND-CKD Study Investigators. Nephrol Dial Transplant; 2014 Nov 26; 29(11):2075-84. PubMed ID: 24891437 [Abstract] [Full Text] [Related]
13. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Gasche C, Dejaco C, Reinisch W, Tillinger W, Waldhoer T, Fueger GF, Lochs H, Gangl A. Digestion; 1999 Nov 26; 60(3):262-7. PubMed ID: 10343140 [Abstract] [Full Text] [Related]
14. [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. Li H, Wang SX. Zhonghua Yi Xue Za Zhi; 2009 Feb 24; 89(7):457-62. PubMed ID: 19567093 [Abstract] [Full Text] [Related]
15. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. Cançado RD, Brasil SA, Noronha TG, Chiattone CS. Rev Assoc Med Bras (1992); 2005 Feb 24; 51(6):323-8. PubMed ID: 16444338 [Abstract] [Full Text] [Related]
16. Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia. Cococcioni L, Pensabene L, El-Khouly S, Chadokufa S, McCartney S, Saliakellis E, Kiparissi F, Borrelli O. Dig Liver Dis; 2021 Jul 24; 53(7):830-834. PubMed ID: 33775573 [Abstract] [Full Text] [Related]
17. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders. Takasawa K, Takaeda C, Wada T, Ueda N. Nutrients; 2018 Mar 29; 10(4):. PubMed ID: 29596361 [Abstract] [Full Text] [Related]
18. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Beigel F, Löhr B, Laubender RP, Tillack C, Schnitzler F, Breiteneicher S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S. Digestion; 2012 Mar 29; 85(1):47-54. PubMed ID: 22179489 [Abstract] [Full Text] [Related]
19. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Li H, Wang SX. Perit Dial Int; 2008 Mar 29; 28(2):149-54. PubMed ID: 18332450 [Abstract] [Full Text] [Related]
20. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M. Am J Kidney Dis; 1996 Feb 29; 27(2):234-8. PubMed ID: 8659499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]